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Abstract: The advent of mesoporous bioactive glasses (MBGs) in applied bio-sciences led to the
birth of a new class of nanostructured materials combining triple functionality, that is, bone-bonding
capability, drug delivery and therapeutic ion release. However, the development of hierarchical
three-dimensional (3D) scaffolds based on MBGs may be difficult due to some inherent drawbacks of
MBGs (e.g., high brittleness) and technological challenges related to their fabrication in a multiscale
porous form. For example, MBG-based scaffolds produced by conventional porogen-assisted methods
exhibit a very low mechanical strength, making them unsuitable for clinical applications. The
application of additive manufacturing techniques significantly improved the processing of these
materials, making it easier preserving the textural and functional properties of MBGs and allowing
stronger scaffolds to be produced. This review provides an overview of the major aspects relevant
to 3D printing of MBGs, including technological issues and potential applications of final products
in medicine.
Keywords: biomaterials; bioglass; scaffold; mesoporous; additive manufacturing; tissue regeneration;
hierarchical; porosity; drug delivery; ion release; bioactivity
1. Introduction
Bioactive glasses (BGs) were invented by Prof. Larry L. Hench at the University of Florida (US) in
1969 [1,2]. Originally, the “bioactivity” of these materials referred to their unique capability of bonding
to living bone through establishing a tight material/tissue interface while stimulating the expression of
osteogenic factors in bone cells, responsible for the synthesis of new bone [3,4]. It was observed that,
both in vitro and in vivo, chemical reactions mediated by ion exchange mechanisms occur between the
surface of BGs and the surrounding biological fluids, which ultimately leads to the formation of a layer
of nano-crystalline hydroxyapatite (HA) at the bone/implant interface [5]. This newly-formed phase is
very similar to the calcium phosphate mineral phase (bioapatite) of bones in mammals [6]. Recently,
some special BG compositions were also found potentially suitable for applications in contact with soft
tissues, such as peripheral nerve repair [7] and wound healing [8].
The first BG developed by Hench belonged to a silicate system obtained by traditional
melt-quenching process [9]. It was characterized by a quaternary oxide composition
(45SiO2-6P2O5-24.5Na2O-24.5CaO wt.%) and has been commercially available on the market since
1984 with the tradename of 45S5 Bioglass®; since then, the biomaterials community has been engaged
in a stimulating research activity on BGs aimed at further improving the promising results already
obtained in healthcare [10].
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The 45S5 Bioglass® composition, as well as most of silicate BGs produced by traditional
melt-quenching route, are affected by some inherent limitations including high processing temperatures
required for casting (>1500 ◦C) and unavoidable devitrification upon sintering, which resulted in a
decrease of the bioactive properties [11]. Another important issue is the strong relationship existing
between BG composition and HA-forming ability. In melt-derived silicate systems, high amounts
of SiO2 (>60 mol.%) suppress the HA-forming ability of the material and, hence, the bone-bonding
mechanism. The reason behind this behavior is that the higher the amount of SiO2, the higher the
chemical stability of the glass network. As a result, there is a decrease of BG dissolution rate, ionic
release and exposure of hydroxyl (—OH) groups, which act as a nucleation site for HA on the glass
surface [12].
Apart from being produced by traditional melt-quenching, BGs can also be synthesized by
the sol-gel process. Such BGs, which began to be studied in the early 1990s, exhibit dramatically
appealing features for bone tissue engineering applications [13]. Sol-gel synthesis is commonly
defined as a chemical processing technique based on three steps: (i) preparation of a sol, that is, a
precursor-containing colloidal solution, (ii) gelation of the sol and (iii) removal of the solvent by
thermal treatment [14]. From a technological viewpoint, the major advantage of sol-gel materials over
melt-derived materials is that high temperatures are not required in a wet synthesis, since the formation
of the gel occurs at room temperature due to hydrolysis and poly-condensation reactions catalyzed
by a proper chemical agent [15]. Interestingly, gel-derived BGs exhibit a wider compositional range
allowing bioactivity and SiO2 can be included in the system up to 90 mol.% without any suppression
of HA formation or significant decrease of the relevant reaction kinetics [13,16]. An explanation of this
attractive property is that, unlike melt-derived BGs, sol-gel materials are typically characterized by
an inherent mesoporosity and higher surface area (>50 m2/g vs. less than 1 m2/g), which boosts the
ion-exchange mechanisms, allowing faster deposition of HA [17–19].
A polymeric template can be introduced in the sol-gel process as a structure directing agent (SDA)
to finely tailor the textural properties of the glasses, like mesopore size, distribution and orientation. In
“traditional” sol-gel materials (without SDA), the distribution of mesopores is disordered, quite broad
and pore size can largely vary between 2 and 50 nm [20].
Owing to the presence of an inherent mesoporosity, gel-derived glasses are typically affected by
lower mechanical properties compared to melt-derived ones, which has limited their application to the
repair of non-load-bearing osseous sites [13]. To the best of the authors’ knowledge, to date only one
gel-derived mesoporous glass composition (70SiO2–30CaO mol.%) reached the market and was cleared
for clinical application in bone repair (TheraGlass®, MedCell, Burgess Hill, UK) [21]. The interested
reader is referred to other recent review papers on BGs and related clinical applications [22,23].
The introduction of additive manufacturing technologies in the field of BGs and, especially,
gel-derived BGs is showing great promise for expanding the applications of these materials and
overcoming the barriers to clinical translation in the future. This “hot” research field is explored in the
present review, which was prepared by carrying out a literature search on the database SCOPUS using
the keywords “mesoporous,” “bioactive glass,” “scaffold,” “3D printing” and their combinations.
2. Mesoporous Bioactive Glasses (MBGs): An Overview
Over the last two decades, ordered mesoporous materials, characterized by high surface area and
well-organized mesoporous texture, have been gaining increasing scientific interest in biomedicine.
Various types of mesoporous silicas (e.g., SBA-15, MCM-41) were initially investigated and proposed
as carriers for drug delivery applications since an ordered mesostructured texture allows a better
control on release kinetics, thus making the therapeutic treatment more effective and confined to
the target area [24–28]. Incorporation of additional oxides in the composition (e.g., CaO and P2O5)
allowed obtaining mesoporous bioactive glasses (MBGs) [29–31], which are potentially able to provide
multiple therapeutic actions by supporting bone tissue ingrowth and regeneration while simultaneously
providing a local treatment of diseased bone through the controlled release of organic (drugs, growth
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factors) or inorganic therapeutic agents (metallic ions) [32–35]. The impressive versatility of these
systems allowed scientists to design them, for example, as multipurpose biomaterials for improving
bone healing, eliciting antiseptic action by introducing specific cations into the MBG structure (e.g., Ag+,
Zn2+, Cu2+, Ga2+, Ce3+ and Ce4+) [36–38] or even targeting to tumor therapy [39]. In this regard, it has
been demonstrated that including small amounts of Fe2O3 in MBGs is sufficient to induce a magnetic
response of the material after exposure to an external magnetic field, which results in a localized
production of heat [40]—this effect can lead to the selective death of cancer cells by hyperthermia [39].
The production of MBGs relies upon sol-gel synthesis combined with supramolecular
chemistry [41]. It is worth pointing out that a disordered mesoporosity is inherently present in
bioactive glasses produced via the sol-gel process in the absence of SDAs [13]. SDAs, acting as
mesostructure templates (Figure 1) [16], can be employed to properly tailor the size, distribution
and geometrical arrangement of the mesopores [20]. Looking at most of the existing literature, the
definition “MBG” is conventionally referred to the latter type of sol-gel BGs (with SDA); Figure 2 [16]
provides a further clarification of these issues.
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Figure 1. Schematic illustration of the steps leading to a mesoporous silicate material starting from a 
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Figure 1. Sc e tic ill str ti f t e ste s lea i to a eso oro s silicate aterial starti g fro a
icellar solution: ic ll s fr str ct re irecting agent (S ) li t e rolyze silica precursors
through the hydrophilic component and self-as embly to form an ordered mesophase. Pictures
reproduced from Arcos and Vallet-Regi [16] with permis ion.
Some of the most commonly-used SDAs are cetyltrimethyl ammonium bromide (CTAB) and
nonionic surfactants, such as Pluronic P123 and F127. Under specific and controlled pH and temperature,
surfactant molecules are able to self-organize and create the mesoporous texture through the so-called
evaporation-induced self-assembly process (EISA) [16]. In a typical EISA route [41], the molecules
of the surfactant self-organize into micelles by exposing hydrophilic heads to the synthesis solution
where the glass precursors (e.g., alkoxides or salts) have been added. The so-obtained mixture is
then subjected to a thermal treatment (drying) for the complete removal of solvent; high-temperature
treatments (calcination) are eventually necessary to remove SDA, precursor residues (e.g., nitrates) and
consolidate the material [42].
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Figure 2. High-resolution transmission electron microscope (TEM) images of a silicate SDA-templated
glass (MBG) (top) and a “conventional” sol-gel glass (without SDA) (bottom). Mesopores in the
mesoporous bioactive glass (MBG) are well ordered according to a hexagonal symmetry. A schematic
representation of alendronate molecule and its interaction with silanol groups at the mesopore surface
are also displayed. Pictures reproduced from Arcos and Vallet-Regi [16] with permission.
Different mesoporous textures can be obtained depending the type of surfactant used [43,44];
TEM images showing the MBG meso-structures r sulting from the use f P123, F-127 and CTAB are
displayed in Figure 3 [33,44].
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Figure 3. TEM images of mesopor us structures obtained by using P123 (a), F-127 (b) and cetyltrimethyl
ammonium bro ide (CTAB) (c) as SDAs in MBGs. Picture reproduc d from Wu et al. [33] and
Yun et al. [44] with permission.
CTAB is known to induce the formation of smaller mesopores (2–3 nm) compared to P123 and F-127
(4–10 nm). Worm-like morphology is typically generated by F-127, while 2D hexagonal mesoporosity
was observed with P123 [32,41].
MBGs can be processed in different forms, including micro-/nano-particles with irregular or
spherical shape, fibers, composite materials and 3D scaffolds; these products can be obtained by
combining EISA method with other processing techniques (e.g., electrospinning for the production of
fibers, hydrothermal methods or spray-drying for the production of micro- and nano-spheres) [45].
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Fabrication of hierarchical MBG-based scaffolds is a challenge—in fact, mesopore size is almost
three orders of magnitude lower than that of osteoblasts and, therefore, macroporosity must be
somehow introduced in the final product in order to allow cell colonization and tissue in-growth [46].
Actually, the first study on the development of hierarchical BG scaffolds was reported by Sepulveda
et al. [47], who applied the foaming technique to the sol. This process involves the acid-catalyzed
preparation of a sol by mixing together alkoxides and a catalyst. Then, a gelling agent (e.g., HF) and a
surfactant are added to the sol that is foamed by vigorous agitation (i.e., air bubbles are introduced into
the sol). As soon as the viscosity increases, the foam is poured immediately before gelation into molds;
then, it is aged, dried and thermally stabilized (calcination). The obtained structure is hierarchical with
both interconnected spherical macropores (deriving from foaming) and mesopores (which are inherent
of the sol-gel process). It is interesting to highlight that, in this method, the surfactant somehow acts
as a forming agent of macropores (Figure 4) The foaming process and calcination conditions were
properly optimized to increase the compressive strength of these scaffolds to 4.5 MPa [48,49].
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Foam replica method is considered one of the most versatile and effective techniques to obtain
porous ceramic or glass scaffolds with bone-like trabecular structure exhibiting high porosity (>90 vol.%)
and satisfactory pore interconnectivity [54,55]. Over time, apart from industrial polyurethane sponges,
other macroporous templates have been proposed for making scaffolds, including natural structures
derived from plants and vegetables [56]. However, scaffolds produced by replication methods are
usually affected by ultralow mechanical strength (<50 kPa in compression [40]), which precludes the
actual possibility of using the device for a safe treatment in vivo even in non-load-bearing sites.
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Higher mechanical performanc s can be achieved by applying porogen methods, in which
polymeri spheres or parti les (e.g., methyl cellulose [44]) are used as a macropore-forming agent that
is thermally removed u n sinteri g. The main drawback of these techniques is the low degree of
interconnectivity between adjacent pores and the relatively low volume of void space, which, combined
with an inefficient control on porosity homogeneity, may preclude cell migration, fluid perfusion and
vascularization after implantation. As a result, in recent years researchers’ attention has moved to
additive manufacturing technologies for processing ceramic and glasses more effectively [57]. These
techniques represent a valuable strategy to overcome most of the existing shortcomings of traditional
fabrication methods for glass and ceramic scaffolds, such as low control on macropore architecture,
low compressive strength and difficult reproducibility; on the other hand, they allow customization of
the scaffold (patient-centered personalized medicine).
3. Fundamentals of 3D Printing and Application to BGs
In th last decad , sever l research groups intensively appli d additive manufacturing
technologies to proc s BGs in the attempt to obt in m chanically-resistant scaffolds wit tailored and
highly-controlled structur eatures.
This br ad class of fabrication technique include laser-assis ed methods (e.g., selective laser
sintering, stere lithography) a d controlled is ensing proc ures (often si ply called 3D printing).
Selective laser sintering employs a laser beam to sinter thin layers of powdered materials to form 3D
objects. The laser beam is scanned over the powder bed following a computer-aided design (CAD)
model, thus rai ing the temperature of powders only in el cted areas. Part cles elt together and
subsequent layers can be built dir ctly on the t p of the prev ously-sintered material [58].
Stereolit graphy uses a blend of glass or ceramic powders and a photocurable monomer. A
UV laser beam, which cures the monomer, is selectively scanned over the surface of the blend
following the cross-sectional profiles of the CAD model; subsequent layers are built directly on top of
previously-cured layers with new layers of blend being deposited. After this step, non-polymerized
material is removed, and sintering is performed to obtain the final product [59].
However, both these strategies require high investment costs to buy the proper equipment;
therefore, the use of relatively affordable 3D printers is often preferred in a lab-scale scenario. The
use of particles below 30 µm and extrusion nozzles between 100–580 µm allows obtaining 3D-printed
BG structures with pores size ranging from few tens of micrometers to half a millimeter, which are
potentially suitable for bone tissue engineering applications [57].
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Generally, total porosity of 3D-printed scaffolds is lower than that obtained by foam replication
and ranges within 50 vol.%–60 vol.%, which corresponds to the lower range of trabecular bone [6].
As a result, high mechanical properties can be achieved—such scaffolds can exhibit a compressive
strength higher than 13 MPa and are then potentially able to match–to some extent–the compressive
resistance of both trabecular and cortical bone [60]. Three-dimensional printing technology allows a
relatively easy fabrication of scaffolds with different patterns characterized by a wide variety of pore
sizes and shapes. BG scaffolds with porosity gradient or multiscale porosity have great potential for
interfacial tissue engineering—for example, the interface between trabecular and cancellous bone can
be mimicked to some extent as different density and porosity values can be easily obtained by the
printing of a proper design.
The 3D printing process builds a 3D object from a CAD model, usually by adding material through
a layer by layer strategy. The most popular and affordable method to produce 3D-printed BG scaffolds
involves the continuous deposition of a glass-based filament onto a building platform [61]. This
approach is also called robocasting or robotic deposition; a schematic representation of a 3D printer for
robocasting is shown in Figure 6 [57].
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ove ents of printing head and building platform, it is possible to obtain highly-regular 3D structures
with a good level of accuracy, resolution and repeatability. Movement instructions are provided by a
dedicated software which connects t e machine to a computer. The software is able to elaborate and
convert either script files (text files) or CAD files in .stl files containing the structural and morphological
features of the scaffold. Some commercial 3D-printing systems were shown to be suitable to fabricate
MBG-based scaffolds, such as Manugel® (ISP Alginates Ltd. Waterfield, Tadworth, UK) and 4th
generation 3D-Bioplotter system (EnvisionTEC, Gladbeck, Germa y).
Despite 3D printing being considered the most effective additive manufacturing technology
for the processing of BGs, there are some aspects to be considered in order to obtain good printing
outcomes. In fact, the quality of the final scaffold is strongly dependent on the extrusion process and
the characteristics of the ink used for printing. In order to ensure a good outcome of the process and
reliably reproduce the given pattern, a proper setting of printing parameters is needed in accordance
with the rheological properties of the ink [61]. From a qualitative point of view, it is of paramount
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importance to maintain the filament straight upon extrusion to avoid the distortion of the structure
and to preserve the original design. Moreover, as the scaffold is produced by continuous deposition of
adjacent layers, the “strength” of the ink has to be high enough to avoid the collapse of the structure,
which may also result in a deformation of the tailored 3D architecture. Another common issue concerns
the formation of clogs in the nozzle during extrusion, which may result in material gaps in the scaffold
or even the blocking of the printing process. All these aspects should be managed by operating a strict
control on the ink properties.
The inks used for this kind of applications are usually suspensions obtained by mixing BG particles
in an aqueous solution containing a polymeric binder, which is added to provide stability to the
mixture [62]. Specifically, a good ink for 3D printing should exhibit the following properties [62]: (i)
pseudo-plasticity, which allows the ink to flow through a small-diameter nozzle without applying
high air pressure; (ii) non-flowable mass, in order to preserve the shape after deposition; and (iii) high
strength, thus being able to withstand the weight of the overlying structure. Pluronic F-127 is one of
the most commonly-used binders for 3D printing in bone scaffold applications [63–65], together with
ethyl cellulose, polyethylene glycol and carboxymethyl cellulose [66–69].
One of the key aspects of 3D printing concerns the capability of the ink to change its rheological
properties under the action of particular chemical or physical conditions, such as external temperature
or the drying process, in order to have a consolidated and “fixed” structure [63,70]. Delivery of the
ink can take place according to two different configurations. In the first case, the ink is delivered by a
constant displacement of the plunger inside the syringe, where the pressure is properly modulated for
maintaining such displacement constant over time. The second configuration involves the maintenance
of a constant pressure inside the syringe [71]. Controlling the displacement of the plunger is considered
the most effective and reliable strategy to ensure a homogeneous delivery of the material on the
building platform; on the contrary, maintaining a constant pressure may be difficult due to the changes
that can occur in the rheological behavior of the ink, as explained above.
The quantity of material (ink) which is deposited on the building platform can be controlled by
two factors, that is, the velocity of displacement of the printing head in the xy (horizontal) plane and the
dispensing pressure. The higher the velocity of displacement, the lower the amount of ink deposited
at a fixed pressure value. On the contrary, the higher the pressure used to extrude the filament, the
thicker the deposited filament (rod). Therefore, although these two parameters can be set separately
and are independent of each other, they need to be jointly adjusted as their variations have an effect on
the same result.
Another factor to be considered is the spacing along the vertical axis (z-spacing), which runs
perpendicularly to the building platform. The z-spacing determines and controls the adhesion between
adjacent layers and, thus, needs to be adjusted according to some specifications like the mean thickness
of the rods and the diameter of the nozzle. If the z-spacing is too low, the movement of the nozzle can
destroy the printed layers by touching them, while if it is too large, the gap is too high to allow the
adhesion between the layers.
In order to allow good reproducibility of the layers and periodicity of the structural features of
the scaffold, the building platform should be flat and perpendicular to the extrusion axis. It is common
to use flexible substrates, such as acetate sheets, in order to facilitate the detachment of the scaffold
from the substrate after drying [72,73].
Drying conditions should also be carefully controlled in order to avoid crack formation due to
sudden water elimination and shrinkage of the structure. 3D-printed scaffolds are usually affected
by inhomogeneous drying conditions from the top of the structure to the bottom, which is in contact
with the printing substrate. The top of the scaffold usually dries faster than the bottom because air
recirculation is partially inhibited by the contact with the substrate and by the overlying layers. As a
result, the shrinkage of the structure after uncontrolled drying conditions is usually higher at the top
and may result in the formation of cracks in contact with the substrate. This problem can be overcome
by operating a strict control on temperature just after printing. According to the dimensions of the
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printed scaffold, drying may occur at either room temperature or in mild-heating conditions. For large
scaffolds (above 10 mm × 10 mm × 10 mm), treatment in pre-heated ovens may be helpful to avoid
drying gradients in the 3D structure.
Figure 7 summarizes the most recurrent issues related to the processing of BGs by 3D
printing technology.
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4. Application of 3D Printing to MBGs
3D printing has been successfully employed in the production of scaffolds for bone tissue
engineering exhibiting hierarchical porosity. As discussed in the Section 3, under proper processing
parameters, 3D printing allows a better control on morphological and structural features compared
to traditional manufacturing techniques. This leads to better mechanical performances that make
3D-printed scaffolds potentially suitable even for load-bearing applications.
Hierarchical MBG scaffolds were produced by several research groups. The great advantage of
3D printing is that the 3D structure is built following a layer-by-layer approach at room temperature,
thus potentially allowing mass production of several devices characterized by structural, mechanical
and morphological features varying in a very narrow range (high reproducibility). A summary of
representative process parameters and synthesis details used in 3D printing of MBG scaffolds is
provided in Table 1 [74–82].
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Table 1. Selection of studies along with the process parameters, synthesis details and structural/textural
features of 3D-printed MBG scaffolds.
Composition MesoporeSDA
Binding
Agent
Dispensing
Pressure
(kPa)
Printing xy
Speed
mm/s
Macropore
Size
(µm)
Porosity
(vol.%)
Compr.
Strength
(MPa)
BET Surface
Area
(m2/g)
Ref.a
SiO2-P2O5 MBG F-127 MC
Adapted
during
printing
Adapted
during
printing
400 40 - 152–310 [74]
SiO2-CaO-P2O5
MBG P123 PVA 520–590 3 200–1300 60 ~16.10 - [75]
SiO2-CaO-P2O5
MBG doped with Ce,
Ga and Zn
P123 PCL - 5.3
UL > 400
MP =
100–400
- - 398 [76]
SiO2-CaO-P2O5
MBG doped with Sr P123 PVA 150–380 9–12 ~400 70 - ~200 [77,78]
CSH/
SiO2-CaO-P2O5
MBG
P123 PCL 220–360 4.5–8.2 350 66.7–68.3 4.5–12.8 356 [79]
SiO2-CaO-P2O5
MBG/alginate
composite
P123 Alginate 180–250 15 344–415 49.5–50.8 0.5–1.5 - [80]
SiO2-CaO-P2O5
MBG/PCL composite F-127 PCL - 10 190 75–84 - 520 [81]
Carboxylic-modified
SiO2-CaO-P2O5
MBG
P123 PHBHHx - - ~250 - 3.15 63–330 [82]
a Reference numbering in the table follows the numbering in the main text. Legend: UL: Ultra Large Pores; MP:
Macropores; CSH: Calcium Sulfate Hydrate; MC: methyl cellulose; PCL: poly(caprolactone); PVA: poly(vinyl
alcohol); PHBHHx: poly(3-hydroxybutyrate-co-3-hydroxyhexanoate).
The production of several macroporous structures characterized by different macropore size
and shape was extensively reported to be obtainable by operating proper modification to the text
script/CAD file. Figure 8 shows that rectangular, triangular and squared macropores can be successfully
obtained in 3D-printed MBG scaffolds.
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Figure 8. SEM images showing different macropore morphologies that can be obtained by 3D printing
of MBGs: (a) squared, (b) rectangular and (c,d) irregular (triangular pattern) macropores. The high
regularity of the pattern is well appreciable and macropore size is characterized by a narrow distribution.
Pictures reproduced from Zhang et al. [77] and Wu et al. [75] with permission.
Referring to the values reported in Table 1, MBG scaffolds having macropores with size >200 µm
and porosity >50 vol.% are potentially suitable for bone tissue engineering applications. In fact, these
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values are adequate to support proper tissue ingrowth and regeneration by allowing cell migration
through the whole volume of the scaffold. Moreover, highly interconnected macropores have been
demonstrated to promote the formation of a well-organized vascular network, the recirculation of
body fluids and thus the diffusion of nutrients and the elimination of catabolites [83,84].
A key characteristic of MBG scaffolds is their exceptional ability to form an HA layer on their
surface and struts due to the ultrahigh specific surface area (SSA), which is mainly determined
by their mesoporous texture. Bioactivity and mesoporosity are intimately related since the higher
the surface exposed to biological fluids, the higher the reaction rate of the material and, hence,
its bioactivity [17,18,85]. N2 adsorption-desorption measurements are commonly used to assess
SSA and mesopore size distribution by the implementation of the Brunauer-Emmett-Teller (BET)
theory. MBG-based scaffolds are usually characterized by higher SSA compared to analogous systems
based on melt-derived glass powders. Type-IV N2 adsorption-desorption isotherms (according to the
classification provided by the International Union of Pure and Applied Chemistry (IUPAC) [86]), typical
of mesoporous materials with narrow and ordered mesopore distribution, are usually observed [74].
SSA values of MBGs can vary within 150–400 m2/g depending on the mesopore-directing agent used
(Table 1).
At present, there is no standardized protocol to follow for the preparation of a “good” ink with
optimal rheological properties for a continuous and homogeneous extrusion of the filament. This is
due to the strong interdependence that exists among ink rheological behavior, binder solution, glass
composition and particle size. In general, all these parameters may be subjected to a great variation
and, over time, different approaches have been experimented, each one presenting both advantages
and disadvantages. The ink is usually a suspension of MBG particles into a binder/water solution. The
concentration of the binder solution and the final composition of the slurry determine the properties of
the ink. In this regard, sol-gel synthesis offers the possibility to obtain a slurry with suitable extrusion
properties by simply acting on aging time of the sol in order to match appropriate rheological properties
for printing [74].
In some preliminary studies concerning the 3D-printing of MBGs, hydroxyl propyl methylcellulose
was proposed as a binding agent to confer proper rheological properties for the extrusion [74,87,88].
Garcia et al. [74] first reported the synthesis of 3D hierarchical scaffolds based on a binary SiO2-P2O5
MBG. A traditional sol-gel synthesis was applied for the material preparation using tetraethyl
orthosilicate (TEOS) and triethyl phosphate (TEP) as SiO2 and P2O5 precursors, respectively. The
synthesis was carried out by mixing the precursors in an ethanol/water solution in the presence of
HCl (1 M) as a catalyst for the hydrolysis reaction. In order to achieve good rheological response for
printing, several aging times have been tested before adding the binder (cellulosic compound) [74].
Material feed and pressure have been continuously modified during printing in order to manage
viscosity variation of the ink. Hardening was carried out by keeping the scaffolds at room temperature
for 24 h; then, the consolidated “greens” were sintered at high temperature to remove the organic
binder (hydroxyl propyl methylcellulose) [74]. Aging period from 8 to 22 h produced a viscosity in the
range of 2–3 Pa, with good flowing properties upon extrusion and rapid transformation of the ink into
a solid state after contact with the building platform [74].
A dependence of MBG textural properties on the phosphorus content in the binary SiO2-P2O5
systems was observed—specifically, SSA was found to decrease as a result of the increase in P2O5
content compared to pure SiO2 samples, consistently to previous studies about the incorporation of
heteroelements into the mesoporous silica network [89]. Hierarchical porosity was obtained with
ordered mesopores of 4 nm, macropores in the rage 30–80 µm and ultra-large macropores of 400 µm.
Degradation of organics during high-temperature sintering may lead to the formation of micro-scale
porosity, which decrease the mechanical resistance of the device [74]. In order to overcome this problem,
some research groups replaced methylcellulose with polyvinyl alcohol (PVA), which is known to be
highly biocompatible, highly degradable and soluble in water [75]. Wu and coworkers used MBG
powders (ternary glass with Si/Ca/P molar ratio of 80/15/5) to produce a suspension based on an aqueous
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PVA solution—in this case, scaffolds were not subjected to a sintering treatment but, after printing,
were dried at low temperature and then heated up to 150 ◦C to thermally induce the cross-linking
of PVA [75]. This approach allowed obtaining sintered scaffolds with higher mechanical properties
due to the increase in PVA crystallinity as a result of the low-temperature thermal treatment. The
compressive strength and elastic modulus of the scaffolds, characterized by square-pore morphology
and porosity of 60.4 vol.%, were 16.10 ± 1.53 and 155.13 ± 14.89 MPa, respectively [75]. Moreover,
a linear relationship between compressive strength and scaffold deformation was found for these
3D-printed scaffolds, compared to the irregular increase observed for foam-templated MBG scaffolds
characterized by a jagged stress-strain curve with a maximum compressive peak of 0.08 MPa [86].
An analogous approach was also used for producing Sr-doped MBG-based scaffolds as
dexamethasone (DEX)-releasing hierarchical systems. In this case, the compressive strength was about
8–9 MPa; just a small decrease of strength to 7 MPa was observed after immersion in simulated body
fluid (SBF), which was attributed to the persistence of PVA with high degree of polymerization (1700 ±
50 Da), resulting in a slower dissolution of the system in aqueous solution [77].
Other polymers were also tested for producing MBG-containing composite scaffolds. 3D-printed
hierarchical MBG/alginate composite scaffolds showed good biocompatibility, sustained drug delivery
properties and HA-forming ability in vitro; however, the compressive strength significantly decreased
from 1–1.5 MPa to 0.5–0.8 MPa after immersion for 28 days in SBF [80].
Yun et al. [81] combined salt leaching and 3D printing to fabricate MBG/polycaprolactone (PCL)
composite scaffolds exhibiting three-level multiscale porosity, including mesopores of 5 nm, mid-size
macropores within 2–9 µm and large macropores around 200 µm. The scaffolds were fabricated by
directly extruding the composite ink onto a chilled plate through a syringe with nozzle of 500 µm in a
displacement-controlled mode. These composite scaffolds exhibited adequate compressive strength
(2–4 MPa) for bone repair, good in vitro bioactivity and, very interestingly, a sponge-like pliable nature
that may suggest a possible use in bone/cartilage interfacial tissue engineering (Figure 9) [81].
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In general, as also summarized in Table 1, it is worth pointing out that the mechanical strength of
3D-printed MBG scaffolds is comparable to that of human cancellous (2–12 MPa in compression [90]),
which is not achievable by using conventional fabrication methods.
5. Therapeutic Applications
Small amounts of doping elements can play a key role in modulating the scaffold functional
properties. For example, strontium was added as a dopant to SiO2-CaO-P2O5 MBG compositions
due to its role in combating osteoporosis (antiresorptive effect on bone, stimulation of osteoblast
differentiation [91–93]). Interestingly, unlike what was observed for melt-derived Sr-doped BGs, the
HA-forming ability was not decreased by the strontium content in Sr-containing MBG scaffolds [94],
indicating that these materials were still potentially able to induce the formation of a stable bone-bonding
interface. 3D-printed Sr-doped MBG scaffolds were also implanted in rat critical-sized defects [78].
In vivo evidence revealed that these systems, characterized by an ordered mesoporous texture, regular
macroporosity (400 µm) and high porosity (70 vol.%), were able to induce bone cell adhesion,
proliferation and differentiation. Moreover, such scaffolds exhibited an excellent HA-forming ability,
thus ensuring primary stability to the implant and high compressive strength (about 8 MPa) for
providing adequate mechanical support to the surrounding tissue.
Other therapeutic ions have also been incorporated within 3D-printed MBG scaffolds. In general,
this approach is considered to be cost-effective and technologically easier compared to the use of
organic biomolecules, also considering that metallic ions undergo no degradation upon manufacturing
processes as may occur for thermally-degradable drugs. Shruti et al. [76] prepared 3D-printed Ce-,
Ga- and Zn-doped hierarchical MBG-based scaffolds by using P123 as a mesopore SDA and cerium,
gallium and zinc nitrates as precursors of the doping oxides. These dopants are known to elicit an
antibacterial effect, although this specific property was not investigated in that study. The ink for 3D
printing was prepared by sonication of MBG powders in dichloromethane. After that, PCL granules
were dissolved in the same volume of dichloromethane under magnetic stirring. Then, the two batches
were mixed together, and the so-obtained mixture was left to evaporate under continuous stirring
until an injectable ink was obtained [76]. These scaffolds were found to be potentially able to induce
vascularization as well as to support oxygen exchange and cell in-growth; it was also observed that
textural properties and bioactive potential were successfully retained after printing. Interestingly, the
HA-forming ability and textural properties of the scaffolds were comparable to those assessed for
starting MBG powders. SEM morphological assessments after immersion for 7 days in SBF revealed
the presence of a nanostructured HA layer characterized by the typical bone-like globular cauliflower
morphology [76].
In the context of antibacterial strategies, Zhang et al. [95] used the spin-coating technique to
deposit a thin layer (thickness 100 nm) of Cu-doped MBG on 3D printed β-TCP scaffolds to impart
enhanced bone-forming ability and antiseptic properties due to the local release of copper ions.
Studies concerning the drug delivery ability of 3D-printed MBG scaffolds revealed a burst release
of a model drug (DEX) within the first 48 h, which is particularly indicated for providing primary
therapeutic action in acute inflammatory phase as soon after the device implantation [77]. A slower
release was then observed, which is suitable for a long-term maintenance of the therapeutic effect.
In vivo studies (rat model) confirmed what observed in vitro and reported the total depletion of the
drug after 2-week implantation [78]. Simultaneous incorporation of two drugs (isoniazid and rifampin)
in 3D-printed MBG scaffolds for the treatment of osteoarticular tuberculosis [82].
Zhang et al. [96] proposed the use of 3D-printed MBG/PCL composite scaffolds embedding
magnetite (Fe3O4) nanoparticles in the context of cancer treatment. Specifically, the scaffolds had
uniform macropores of 400 µm, porosity of 60 vol.% and compressive strength within 13–16 MPa.
The incorporation of magnetite nanoparticles did not negatively affect the HA-forming property of
scaffolds but endowed them with magnetic heating ability and significantly stimulated the proliferation,
alkaline phosphatase activity, osteogenesis-related gene expression (RUNX2, OCN, BSP, BMP-2 and
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Col-1) and extra-cellular matrix mineralization of human bone marrow-derived mesenchymal stem
cells. Moreover, Fe3O4/MBG/PCL composite scaffolds exhibited a sustained drug release capability for
doxorubicin (DOX), used as a model anticancer drug. Therefore, these 3D-printed scaffolds showed
great promise as multifunctional implants for simultaneous cancer treatment (magnetic hyperthermia
combined with local drug release) and bone regeneration (enhanced osteogenic activity) at the site of
tumor removal.
Liu et al. [97] recently reported the laser-induced photothermal properties of Cu-, Fe-, Mn-
and Co-doped 3D-printed bioactive scaffolds based on sol-gel glass-ceramics for application in
cancer treatment (Figure 10). After being implanted in rabbits, the materials were capable of killing
tumor cells due to thermal effect, and displayed excellent bone-forming activity by stimulating the
osteogenic differentiation of bone-forming cells. The combination of photothermal cancer therapy
and bone regeneration represents a new strategy for the treatment of osseous tumors by using
bifunctional scaffolds.
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The use of MBGs for the production of scaffolds by 3D printing is recognized to have a great
potential in the manufacturing of bioactive synthetic bone substitutes. The clear advantages offered
by additive manufacturing represent a valuable strategy to overcome the most common limitations
of traditional fabrication processes for glass and ceramic scaffolds, for example, poor reproducibility
and control on the final 3D structure as well as low mechanical strength. Moreover, the highly
tailorable textural properties exhibited by mesoporous materials under proper synthesis conditions
were found to be key in the fabrication of multifunctional systems able to simultaneously provide bone
healing support and therapeutic action through the local delivery of drugs and/or biologically-active
ions. Further efforts should be made in order to define standardized protocols for both the printing
process and the synthesis of mesoporous materials in order to promote the extensive use of 3D-printed
MBG-based scaffolds in the clinical practice, thus overcoming the current drawbacks related to the
usage of biological bone grafts for the treatment of critical-sized bone defects also in load-bearing sites.
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